Evidence map›Paper›PMID 36553072›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Petros Ioannou, Diamantis P Kofteridis, Konstantinos Alexakis, Christos Koutserimpas, Ioanna Papakitsou, Sofia Maraki, George Samonis

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  4. Increase in candidemia cases and emergence of fluconazole-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Petros IoannouCOVID-19 Department, University Hospital of Heraklion, 71500 Heraklion, Greece.ORCID 0000-0003-1082-5674
Diamantis P KofteridisCOVID-19 Department, University Hospital of Heraklion, 71500 Heraklion, Greece.ORCID 0000-0003-0255-5926
Konstantinos AlexakisCOVID-19 Department, University Hospital of Heraklion, 71500 Heraklion, Greece.
Christos KoutserimpasDepartment of Orthopaedics and Traumatology, "251" Hellenic Air Force General Hospital of Athens, 11525 Athens, Greece.
Ioanna PapakitsouCOVID-19 Department, University Hospital of Heraklion, 71500 Heraklion, Greece.
Sofia MarakiDepartment of Clinical Microbiology, University Hospital of Heraklion, 71500 Heraklion, Greece.ORCID 0000-0003-0945-1732
George SamonisDepartment of Medicine, University of Crete, 71500 Heraklion, Greece.
University Hospital of Heraklion · GRHellenic Air Force · GRUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), a disease characterized by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has so far led to hundreds of millions of infections and millions of deaths. Fungal infections are known to complicate COVID-19 patients and are associated with significant morbidity and mortality. The aim of this study was to assess the incidence of positive cultures for

Indexed as

CandidaCOVID-19fungal infectionSARS-CoV-2

Identifiers

PMID36553072
PMCPMC9776868
OpenAlexW4311717182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.